Pharmaceutical Technology Upgradation Assistance Scheme for MSMEs

Syllabus: General Studies Paper 2

MSMEs have availed the benefit under erstwhile PTUAS scheme. However, the PTUAS has been incorporated as a sub-scheme under the Scheme – Strengthening of Pharmaceutical Industry (SPI), which was launched in July 2022.

Three components, to provide infrastructure support for pharma MSMEs in clusters and to address the issues of technology upgradation of individual pharma MSMEs :-

• Assistance to Pharmaceutical Industry for Common Facilities (API-CF)
• Pharmaceutical Technology Upgradation Assistance Scheme (PTUAS
• Pharmaceutical & Medical Devices Promotion and Development Scheme (PMPDS)

About the PTUAS Scheme

• PTUAS is a credit linked scheme and under this, applications are invited from eligible Pharma MSME units since 01.08.2022. 
• For registration of application, online portal has been developed by SIDBI, the Project Management Consultant (PMC) of the scheme and details are available at https://spi.udyamimitra.in.
• The sub-scheme PTUAS is aimed to facilitate Micro, Small and Medium Pharma Enterprises (MSMEs) of proven track record to meet national and international regulatory standards (WHO-GMP or Schedule-M), interest subvention or capital subsidy on their capital loans will be provided, which will further facilitate the growth in volumes as well as in quality and it is ensivaged to support about 400 Pharma MSME units under this sub-scheme during the scheme tenure.
• SIDBI is the Project Management Consultant (PMC) of the scheme.

Question: Identify the factors responsible for the location of Pharmaceutical industry.